Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Carlos Benítez-Barrera, PhD, quien lidera el laboratorio de Experiencias Auditivas Pediátricas y el Cerebro, está interesado en el impacto de experiencias auditivas tempranas, desarrollo del lenguaje, y percepción del habla en niños. También trae nuevas técnicas para ayudar a impulsar este campo de investigación.
Carlos Benítez-Barrera, PhD, who leads the Pediatric Auditory Experience and Brain lab, is interested in the impact of early auditory experiences, language development, and speech perception in kids and brings new technical expertise to help advance the field.
Birth weight (BW) at delivery is an important developmental milestone indicative of prenatal conditions and portends of the postnatal growth trajectory that will occur during infancy and childhood.
Sabrina Huang, a rising senior in the Waisman lab of Xinyu Zhao, PhD, was awarded inaugural support from the endowed Morris H. Aprison Scholar Fund for Undergraduate Research.
Peggy Modaff, MS, CGC, a distinguished clinical genetic counselor in the department of pediatrics and clinic coordinator of the Bone Dysplasia Clinic, was selected to serve on the medical advisory board for the non-profit organization Little People of America (LPA).
PET amyloid [11C]PiB imaging has revealed early detection of Aβ in the striatum in individuals with Down Syndrome (DS), a group carrying genetic risk for AD.
The variability of severity in hypoxia ischemia (HI) induced brain injury among research subjects is a major challenge in developmental brain injury research.
Assessing the impact of interdisciplinary training programs is highly desirable and needed. However, there are currently no established methods to prospectively assess long-term outcomes of trainees compared to individuals who did not receive training.
Neurodevelopmental impairment contributes to the hallmark cognitive disability in individuals with Down syndrome (DS, trisomy 21, T21).
Insulin resistance (IR) has been related to reduced cerebral glucose metabolism in regions identified as hypometabolic in Alzheimer’s clinical syndrome. Insulin secretion (IS) has been less studied than IR despite findings that decreased IS is an early indicator of future type 2 diabetes and a potential predictor of Alzheimer’s clinical syndrome.
